201 related articles for article (PubMed ID: 36970852)
1. In-silico targeting TMPK from monkey pox virus: Molecular docking analysis, density functional theory studies and molecular dynamic simulation analysis.
Sib Tul Hassan Shah S; Naeem I
J Biomol Struct Dyn; 2023; 41(24):14689-14701. PubMed ID: 36970852
[TBL] [Abstract][Full Text] [Related]
2. In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs.
Sahoo AK; Augusthian PD; Muralitharan I; Vivek-Ananth RP; Kumar K; Kumar G; Ranganathan G; Samal A
Mol Divers; 2023 Oct; 27(5):2169-2184. PubMed ID: 36331784
[TBL] [Abstract][Full Text] [Related]
3. Design peptide and multi-epitope protein vaccine candidates against monkeypox virus using reverse vaccinology approach: an in-silico study.
Jahantigh HR; Shahbazi B; Gouklai H; Van der Weken H; Gharibi Z; Rezaei Z; Habibi M; Ahmadi K
J Biomol Struct Dyn; 2023; 41(23):14398-14418. PubMed ID: 37154825
[TBL] [Abstract][Full Text] [Related]
4.
Lokhande KB; Shrivastava A; Singh A
J Biomol Struct Dyn; 2023; 41(23):14259-14274. PubMed ID: 36841550
[TBL] [Abstract][Full Text] [Related]
5. A review on computational studies and bioinformatics analysis of potential drugs against monkeypox virus.
Hossain FMA; Bappy MNI; Robin TB; Ahmad I; Patel H; Jahan N; Rabbi MGR; Roy A; Chowdhury W; Ahmed N; Prome AA; Rani NA; Khan P; Zinnah KMA
J Biomol Struct Dyn; 2024 Aug; 42(12):6091-6107. PubMed ID: 37403283
[TBL] [Abstract][Full Text] [Related]
6. Screening of potential inhibitors against structural proteins from Monkeypox and related viruses of
Kaur M; Sharma A; Kaur H; Singh M; Devi B; Naresh Raj AR; Sood V; Pandey A; Gartia J; Kumar R; Suresh Babu AR; Singh G; Barnwal RP
J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37776002
[TBL] [Abstract][Full Text] [Related]
7. Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus.
Ajmal A; Mahmood A; Hayat C; Hakami MA; Alotaibi BS; Umair M; Abdalla AN; Li P; He P; Wadood A; Hu J
Front Cell Infect Microbiol; 2023; 13():1159389. PubMed ID: 37313340
[TBL] [Abstract][Full Text] [Related]
8. Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach.
Akash S; Hossain A; Hossain MS; Rahman MM; Ahmed MZ; Ali N; Valis M; Kuca K; Sharma R
Front Cell Infect Microbiol; 2023; 13():1157627. PubMed ID: 37033493
[TBL] [Abstract][Full Text] [Related]
9. Identification of Diosmin and Flavin Adenine Dinucleotide as Repurposing Treatments for Monkeypox Virus: A Computational Study.
Lam TP; Tran VH; Mai TT; Lai NV; Dang BN; Le MT; Tran TD; Trinh DT; Thai KM
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232872
[TBL] [Abstract][Full Text] [Related]
10. An
Dhotre K; Banerjee A; Dass D; Nema V; Mukherjee A
Curr Pharm Des; 2023; 29(38):3060-3072. PubMed ID: 38062661
[TBL] [Abstract][Full Text] [Related]
11. Novel phytochemical inhibitors targeting monkeypox virus thymidine and serine/threonine kinase: integrating computational modeling and molecular dynamics simulation.
Patel M; Bazaid AS; Azhar EI; Gattan HS; Binsaleh NK; Patel M; Surti M; Adnan M
J Biomol Struct Dyn; 2023; 41(23):13679-13695. PubMed ID: 36852556
[TBL] [Abstract][Full Text] [Related]
12. Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
Preet G; Oluwabusola ET; Milne BF; Ebel R; Jaspars M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430762
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel potential inhibitors of monkeypox virus thymidine kinase using molecular docking, molecular dynamics simulation and MM/PBSA methods.
Abdizadeh T
Mol Divers; 2023 Jul; ():. PubMed ID: 37462851
[TBL] [Abstract][Full Text] [Related]
14. Natural photosensitizers potentiate the targeted antimicrobial photodynamic therapy as the Monkeypox virus entry inhibitors: An in silico approach.
Pourhajibagher M; Bahador A
Photodiagnosis Photodyn Ther; 2023 Sep; 43():103656. PubMed ID: 37336465
[TBL] [Abstract][Full Text] [Related]
15. Immunoinformatic-based design of immune-boosting multiepitope subunit vaccines against monkeypox virus and validation through molecular dynamics and immune simulation.
Suleman M; Rashid F; Ali S; Sher H; Luo S; Xie L; Xie Z
Front Immunol; 2022; 13():1042997. PubMed ID: 36311718
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design of promising natural products to inhibit thymidylate kinase from Monkeypox virus and validation using free energy calculations.
Khan A; Adil S; Qudsia HA; Waheed Y; Alshabrmi FM; Wei DQ
Comput Biol Med; 2023 May; 158():106797. PubMed ID: 36966556
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking of monkeypox (mpox) virus proteinase with FDA approved lead molecules.
Arasu MV; Vijayaragavan P; Purushothaman S; Rathi MA; Al-Dhabi NA; Gopalakrishnan VK; Choi KC; Ilavenil S
J Infect Public Health; 2023 May; 16(5):784-791. PubMed ID: 36958173
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel potential inhibitor of thymidylate kinase from Variola virus.
Sinha P; Yadav AK
J Biomol Struct Dyn; 2023; 41(23):14092-14102. PubMed ID: 36907647
[TBL] [Abstract][Full Text] [Related]
19. Biological Characteristics and Pathogenesis of Monkeypox Virus: An Overview.
Kalaba MH; El-Sherbiny GM; Sharaf MH; Farghal EE
Adv Exp Med Biol; 2024; 1451():91-109. PubMed ID: 38801573
[TBL] [Abstract][Full Text] [Related]
20. Vaccinomics to design a multi-epitope-based vaccine against monkeypox virus using surface-associated proteins.
Khan S; Irfan M; Hameed AR; Ullah A; Abideen SA; Ahmad S; Haq MU; El Bakri Y; Al-Harbi AI; Ali M; Haleem A
J Biomol Struct Dyn; 2023 Dec; 41(20):10859-10868. PubMed ID: 36533379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
